Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: A preliminary trial

Biological Psychiatry

Volumn 47, Issue 12, 2000, Pages 1080-1086

  George, Tony P ^a   Chawarski, Marek C ^a   Pakes, Juliana ^a   Carroll, Kathleen M ^a   Kosten, Thomas R ^a   Schottenfeld, Richard S ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Buprenorphine; Clinical trial; Cocaine; Disulfiram; Opioids

Indexed keywords

BUPRENORPHINE; DISULFIRAM; PLACEBO;

ABSTINENCE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAINTENANCE THERAPY; MALE; OPIATE ADDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINALYSIS;

ADULT; ALCOHOL DETERRENTS; BUPRENORPHINE; CHI-SQUARE DISTRIBUTION; COCAINE-RELATED DISORDERS; DISULFIRAM; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; NARCOTIC ANTAGONISTS; SUBSTANCE ABUSE DETECTION; TIME FACTORS;

EID: 0034091252     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00310-8     Document Type: Article

References (23)

1. Caroldi S., DeParis P. Comparative effects of two dithiocarbamates disulfiram and thiram on adrenal catecholamine content and on plasma dopamine β-hydroxylase activity. Arch Toxicol. 69:1995;690-693.
2. Carroll K., Ziedonis D., O'Malley S., McCance-Katz E., Gordon L., Rounsaville B. Pharmacologic interventions for alcohol- and cocaine-abusing individuals. A pilot study of disulfiram and naltrexone. Am J Addict. 2:1993;77-79.
3. Carroll K.M., Nich C., Ball S.A., McCance E., Rounsaville B.J. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction. 93:1998;713-728.
4. Compton P.A., Ling W., Charuvastra V.C., Wesson D.R. Buprenorphine as a pharmacotherapy for cocaine abuse A review of the evidence . J Addict Dis. 14:1995;97-114.
5. Condelli W.S., Fairbank J.A., Dennis M.L., Rachal J.V. Cocaine use by clients in methadone programs Significance, scope and behavioral interventions . J Subst Abuse Treat. 8:1992;203-212.
6. Cubells J.F., van Kammen D.P., Kelley M.E., Anderson G.M., O'Connor D.T., Price L.H., et al. Dopamine β-hydroxylase Two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation . Hum Genet. 102:1998;533-540.
7. Goldstein M., Anagoste B., Lauber E., McKereghan M.R. Inhibition of dopamine β-hydroxylase by disulfiram. Life Sci. 3:1964;763-767.
8. Hameedi F.A., Rosen M.I., McCance-Katz E.F., McMahon T.J., Price L.H., Jatlow P.I., et al. Behavioral, physiologic and pharmacologic interaction of cocaine and disulfiram in humans. Biol Psychiatry. 37:1995;560-563.
9. Higgins S.T., Budney A.J., Bickel W.K., Hughes J.R., Foerg F. Disulfiram therapy in patients abusing cocaine and alcohol. Am J Psychiatry. 150:1993;675-676.
10. Honjo T., Netter K.J. Inhibition of drug demethylation by disulfiram in vivo and in vitro. Biochem Pharmacol. 18:1969;2681-2683.
11. Johnson R.E., Eissenberg T., Stitzer M.L., Strain E.C., Liebson I.A., Bigelow G.E. Buprenorphine treatment of opioid dependence Clinical trial of daily versus alternate-day dosing . Drug Alcohol Depend. 40:1995;27-35.
12. Kosten T.R., Kleber H.D., Morgan C. Treatment of cocaine abuse with buprenorphine. Biol Psychiatry. 26:1989;637-639.
13. Kosten T.R., Rounsaville B.J., Kleber H.D. A 2.5 year follow-up of cocaine use among treated opiate addicts. Arch Gen Psychiatry. 44:1987;281-284.
14. Ling W., Charuvastra C., Collins J.F., Batki S., Brown L.S. Jr, Kintaudi P., et al. Buprenorphine maintenance treatment of opiate dependence A multicenter, randomized clinical trial . Addiction. 93:1998;475-486.
15. McCance-Katz E.F., Kosten T.R., Jatlow P. Chronic disulfiram treatment effects on intranasal cocaine administration - initial results. Biol Psychiatry. 43:1998;540-543.
16. McCance-Katz E.F., Kosten T.R., Jatlow P. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone - a multiple-dose study. Biol Psychiatry. 44:1998;250-259.
17. McCance-Katz E.F., Kosten T.R., Jatlow P. Disulfiram effects on acute cocaine administration. Drug Alcohol Depend. 52:1998;27-39.
18. Meandzija B., O'Connor P., Fitzgerald B., Rounsaville B.J., Kosten T.R. HIV infection and cocaine use in methadone-maintained and untreated intravenous drug users. Drug Alcohol Depend. 36:1994;109-113.
19. Mello N.K., Mendelson J.H., Bree M.P., Lukas S.E. Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science. 254:1989;859-862.
20. Schottenfeld R.S., Pakes J., Ziedonis D., Kosten T.R. Buprenorphine Dose-related effects on cocaine and opioid use in cocaine-abusing opioid dependent humans . Biol Psychiatry. 34:1993;66-74.
21. Schottenfeld R.S., Pakes J.R., Oliveto A., Ziedonis D., Kosten T.R. Buprenorphine vs. methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry. 54:1997;713-720.
22. Strain E.C., Stitzer M.L., Liebson I.A., Bigelow G.E. Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users. Psychopharmacology. 116:1994;401-406.
23. Strain E.C., Stitzer M.L., Liebson I.A., Bigelow G.E. Buprenorphine versus methadone in the treatment of opioid dependence Self-reports, urinalysis and addiction severity index . J Clin Psychopharmacol. 16:1996;58-67.